Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000030566Phase 4Recruiting
Phase 4, randomised, double-blind trial of dexmedetomidine in complications of surgical procedures (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Postoperative complications. Started Mar 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000030566.